Value

Jubilant DraxImage supports healthcare professionals to help them realize the greatest value from the nuclear medicine procedures they perform;  delivering high-quality care, reducing costs, and improving the patient experience. This requires providing exceptional service, as well as investing in the development of radiopharmaceuticals and technologies to advance the growth and expansion of nuclear medicine.

JDI continuously strives to showcase the value of Nuclear Medicine by funding Physician Initiated Research and Pharmacoeconomic Studies that highlight the benefits of Nuclear Medicine to both physicians and patients.

Studies Include:
  • Studies looking at the impact of V/Q Scan and CTPA Procedures on Healthcare Resource Use and Cost1
  • A 10-year retrospective study showing that younger women are more likely to receive CTPA than V/Q2
  • Thyroid Cancer Center Research funding

References:

  1. Casciano, J, et al, Impact of Ventilation Perfusion Scan and Computed Tomography Pulmonary Angiogram Procedures on Healthcare Resource Use and Cost [abstract16-009], Amer College of Rad, 2016
  2. Casciano, J, et al, Insurance claims linked medical records review in ~80,000 patients focused on V/Q and CTPA imaging in PE shows that younger women are more likely to receive CTPA: A 10 year retrospective analysis of hospital administrative data, J Nucl Med, May 1, 2016 vol. 57 no. 2,1655